Analysis of risk factors for gastric cancer in order to construct tailor-made medicine for gastric cancer
Analysis of risk factors for gastric cancer in order to construct tailor-made medicine for gastric cancer
批准号:
15390231
负责人:
AZUMA Takeshi
金额:
$7.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在cagA阳性的幽门螺杆菌附着在胃上皮细胞上后,cagA通过细菌IV型分泌系统直接从细菌注射到细胞内,并在宿主细胞中经历酪氨酸磷酸化。我们最近发现,易位的CagA与SHP-2形成了物理复合体。SHP-2在促有丝分裂信号转导中发挥着重要的积极作用。CagA对SHP-2的失控可能会导致胃上皮细胞的异常增殖。此外,CagA蛋白是多态的。我们发现,在胃癌高发的东亚地区分离的主要CagA蛋白在CagA的磷酸化位点上有一个独特的序列。东亚特异序列对Western CagA具有较强的SHP-2结合和转化活性。CagA磷酸化位点的多样性共同决定了CagA与SHP-2的结合亲和力,这可能是决定感染临床结局的一个重要变量。我们检测了从日本慢性胃炎或胃癌患者中分离的幽门螺杆菌的CagA多样性。东亚CagA在胃癌患者中的患病率显著高于慢性胃炎患者。与东亚CagA阳性幽门螺杆菌感染相关的胃癌风险为11.8(95%可信限,7.33至383.31)。东亚CagA蛋白毒力较强的幽门螺杆菌种群的地方性循环可能影响胃癌的流行。
英文摘要
After attachment of cagA-positive H. pylori to gastric epithelial cells, CagA is directly injected from the bacteria into the cells via the bacterial type IV secretion system and undergoes tyrosine phosphorylation in the host cells. We recently discovered that translocated CagA forms a physical complex with SHP-2. SHP-2 is known to play an important positive role in mitogenic signal transduction. Deregulation of SHP-2 by CagA may induce abnormal proliferation of gastric epithelial cells. In addition, the CagA protein is polymorphic. We discovered that predominant CagA proteins isolated in East Asia, where gastric cancer is prevalent, have a distinct sequence at the phosphorylation site of CagA. East Asian-specific sequence confers stronger SHP-2 binding and transforming activities to Western CagA. The diversity of the CagA phosphorylation site, which collectively determines binding affinity of CagA to SHP-2, may be an important variable in determining the clinical outcome of infection. We examined the CagA diversity of H. pylori isolated from patients with chronic gastritis or gastric cancer in Japan. The prevalence of East Asian CagA was significantly higher in patients with gastric cancer than in patients with chronic gastritis. The risk for gastric cancer associated with East Asian CagA-positive H. pylori infection was 11.8 (95% confidence limits, 7.33 to 383.31). Endemic circulation of H. pylori populations with more virulent East Asian CagA proteins may affect the prevalence of gastric cancer.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Rare Helicobacter pylori infection as a factor for the very low stomach cancer incidence in Yogyakarta, Indonesia.
罕见的幽门螺杆菌感染是印度尼西亚日惹胃癌发病率极低的一个因素。
DOI:
--
发表时间:
2005
期刊:
Cancer Lett. 219
影响因子:
--
作者:
[Tokudome, S. et al.]
通讯作者:
S. et al.
Azuma T: "Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer"J.Infect.Dis.. 89. 820-827 (2004)
Azuma T:“幽门螺杆菌 CagA 蛋白的含有 Src 同源性 2 结构域的酪氨酸磷酸酶结合位点的多样性与胃萎缩和癌症之间的关联”J.Infect.Dis.. 89. 820-827 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhou W: "The diversity of vacA and cagA genes of Helicobacter pylori in East Asia"FEMS Immunol.Med.Microbiol. 40. 81-87 (2004)
周文:“东亚幽门螺杆菌vacA和cagA基因的多样性”FEMSImmunol.Med.Microbiol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Helicobacter pylori-dependent NF-kappa B activation in newly established Mongolian gastric cancer cell line.
新建立的蒙古胃癌细胞系中幽门螺杆菌依赖性 NF-κ B 激活。
DOI:
--
发表时间:
2005
期刊:
Cancer Sci. 96
影响因子:
--
作者:
[Adachi K., Tsutsui H., 他, Nozaki K]
通讯作者:
Nozaki K
Azuma T: "The effects of cure of Helicobacter pylori infection on the signal transduction of gastric epithelial cells"Aliment Pharmacol.Ther.. 18(Suppll). 39-44 (2003)
Azuma T:“幽门螺杆菌感染的治愈对胃上皮细胞信号转导的影响”Aliment Pharmacol.Ther.. 18(增刊)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Medical application of atmospheric nonthermal plasmas.
-
批准号:26670382
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:AZUMA Takeshi
-
依托单位:
Management of Helicobacter infection and its related gastrointestinal diseases in Asia
-
批准号:25305027
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2013
-
负责人:AZUMA Takeshi
-
依托单位:
Development of endoscopic treatment system using laser
-
批准号:24659366
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:AZUMA Takeshi
-
依托单位:
Development of MR endoscopy
-
批准号:22659146
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:AZUMA Takeshi
-
依托单位:
Epidemiological study for association between Helicobacter infection and gastrointestinal diseases
-
批准号:22406026
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2010
-
负责人:AZUMA Takeshi
-
依托单位:
Metabolome analysis in the gastric carcinogenesis induced by the cross-talk between Helicobacter pylori and host.
-
批准号:21390228
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2009
-
负责人:AZUMA Takeshi
-
依托单位:
Epidemiological research for the relationship between Helicobacter pylori infection and gastrointestinal diseases in Asia
-
批准号:19406025
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2007
-
负责人:AZUMA Takeshi
-
依托单位:
Development of order-made medicine for gastric cancer prevention
-
批准号:18390217
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.89万
-
财政年份:2006
-
负责人:AZUMA Takeshi
-
依托单位:
Function analysis of Helicobacter pylori cag pathogenicity island
-
批准号:13670502
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2001
-
负责人:AZUMA Takeshi
-
依托单位:
Analysis of gastric epithelial lineage
-
批准号:11670488
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:AZUMA Takeshi
-
依托单位:
Cathepsin E expression in pancreatic cancer
-
批准号:09670525
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:AZUMA Takeshi
-
依托单位:
Cancer specific expression of Cathepsin E in pancreas
-
批准号:06670531
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1994
-
负责人:AZUMA Takeshi
-
依托单位:
Rapid diagnostic test for Helicobacter pylori using endoscopic urease probe
-
批准号:06557039
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$5.63万
-
财政年份:1994
-
负责人:AZUMA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CagA+H.pylori通过IRBIT/TRPC6/Ca2+通路促进胃粘膜肠上皮化生的机制研究
-
批准号:82570604
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:谢睿
-
依托单位:
幽门螺杆菌CagA负性调控RUNX1-HDGFRP2抑制胃黏膜上皮细胞同源重组修复的机制研究
-
批准号:82570666
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:胡奕
-
依托单位:
幽门螺杆菌CagA通过调控GPX4降解及核孔转运介导铁死亡在促胃癌发生的机制研究
-
批准号:82560585
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:向田
-
依托单位:
幽门螺杆菌感染者外泌体CagA通过血管平滑肌细胞在动脉粥样硬化中的作用机制研究
-
批准号:2024Y9076
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:林爱萍
-
依托单位:
幽门螺杆菌激活“CagA-CDH3-Wnt/β-catenin”轴驱动胃黏膜肠化生的作用和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:滕永生
-
依托单位:
cagA/线粒体应激协同调控NLRP1依赖的胃上皮细胞泛凋亡在幽门螺杆菌相关胃黏膜炎性损伤中的作用机制研究
-
批准号:82470596
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:吕一品
-
依托单位:
骨髓间充质干细胞源性外泌体靶向幽门螺杆菌CagA促进炎癌转化的调控及免疫逃逸机制
-
批准号:82470219
-
项目类别:面上项目
-
资助金额:48.50万元
-
批准年份:2024
-
负责人:左朝晖
-
依托单位:
幽门螺杆菌毒力蛋白CagA通过调控核孔复合体的形成稳定ZEB1核内表达促进胃癌发生发展的机制研究
-
批准号:82360477
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2023
-
负责人:刘杲
-
依托单位:
CagA抑制端粒酶逆转录酶泛素化降解的分子机制及其在早期肠化生中的作用研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张潇
-
依托单位:
细胞毒素相关基因A阳性幽门螺杆菌(cagA+Hp)通过semaphorin5A抑制自噬促进胃癌发生的机制研究
-
批准号:82260512
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:潘国庆
-
依托单位: